OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Integrins regulate stemness in solid tumor: an emerging therapeutic target
Jiangling Xiong, Lianlian Yan, Cheng Zou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 260

Extracellular matrix-derived mechanical force governs breast cancer cell stemness and quiescence transition through integrin-DDR signaling
Cong Li, Shi Qiu, Xiaohan Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 65

Nanoparticle-based drug delivery systems targeting cancer cell surfaces
Liquan Hong, Wen Li, Yang Li, et al.
RSC Advances (2023) Vol. 13, Iss. 31, pp. 21365-21382
Open Access | Times Cited: 55

Focal adhesion kinase: from biological functions to therapeutic strategies
Ximin Tan, Yuheng Yan, Bin Song, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 54

RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions
Hossein Javid, Mahsa Akbari Oryani, Nastaran Rezagholinejad, et al.
Cancer Medicine (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 54

Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities
Siyi Li, Chibuzo Sampson, Changhao Liu, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 53

Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy
Jiaqiang Xiong, Rourou Xiao, Jiahui Zhao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20

Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11

Magnetic Nanoactuator-Protein Fiber Coated Hydrogel Dressing for Well-Balanced Skin Wound Healing and Tissue Regeneration
Chenlong He, Ming Yin, Han Zhou, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1

Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1

Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 6

Integrin β1 regulates the perineural invasion and radioresistance of oral squamous carcinoma cells by modulating cancer cell stemness
Sung Joon Park, Hyun Jin Min, Changhwan Yoon, et al.
Cellular Signalling (2023) Vol. 110, pp. 110808-110808
Closed Access | Times Cited: 15

Interaction of integrin αvβ3 and fibronectin under fluid shear forces: implications for tumor cell adhesion and migration
Paimin Zhuo, Quhuan Li, Bishan Yang, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets
Zonghao Liu, Xiaofang Zhang, Theresa Ben, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access

Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications
Yoshinobu Kariya, Michiru Nishita
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3143-3143
Open Access

Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer
Meiling Zhang, Bin Zhang
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access

HOXA13 promotes gastric cancer progression partially via the FN1-mediated FAK/Src axis
Zhiwei Qin, Chongzhi Zhou
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 16

SKAP2—A Molecule at the Crossroads for Integrin Signalling and Immune Cell Migration and Function
Marijn Wilmink, Marianne R. Spalinger
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2788-2788
Open Access | Times Cited: 10

An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer
Mengjie Chen, Cheng Zou, Yu Tian, et al.
Oncogene (2024) Vol. 43, Iss. 21, pp. 1594-1607
Closed Access | Times Cited: 3

Mechanobiology of cancer cell responsiveness to chemotherapy and immunotherapy: Mechanistic insights and biomaterial platforms
Delaram Shakiba, Guy M. Genin, Silviya P. Zustiak
Advanced Drug Delivery Reviews (2023) Vol. 196, pp. 114771-114771
Open Access | Times Cited: 9

Advances, challenge and prospects in cell-mediated nanodrug delivery for cancer therapy: a review
Wuhao Wei, Yuansheng Zhang, Zhizhe Lin, et al.
Journal of drug targeting (2022) Vol. 31, Iss. 1, pp. 1-13
Closed Access | Times Cited: 10

The Role of Integrins for Mediating Nanodrugs to Improve Performance in Tumor Diagnosis and Treatment
Chi Yu, Wei Jiang, Bin Li, et al.
Nanomaterials (2023) Vol. 13, Iss. 11, pp. 1721-1721
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top